CAND1 mediates CUL7-dependent HER2 protein stability to drive breast cancer progression

Authors:

Abstract
HER2-positive breast cancer is a prevalent pathological subtype of breast cancer. Resistance to anti-HER2 targeted therapies remains a significant challeng
Funding Information
  • National Natural Science Foundation of China (82373327, 8240111911, 82403028, 82373327, 8240111911, 82403028)
  • Guangdong Basic and Applied Basic Research Foundation (2021A1515110868)
  • Science and Technology Program of Guangzhou (2023A03J0427)
  • Innovation team of general Universities in Guangdong Province (2022KCXTD021)